ALISO VIEJO, Calif., Oct. 17, 2007 (PRIME NEWSWIRE) -- SenoRx Inc. (Nasdaq:SENO) today announced it will release its third quarter financial results on Tuesday, November 13, 2007 following the market close. A conference call to review the results will follow the same day at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time). This call will be open to all investors live via the Investor Relations section of the SenoRx Web site at www.senorx.com. A replay of the call will be available on the company's web site approximately 90 minutes after the call concludes. It will also be available to be downloaded at that time as a podcast.
Details:
What: SenoRx's 2007 Third Quarter Results Conference Call and Webcast
Date: Tuesday, November 13
Time: 2:00 p.m. Pacific Time/5:00 p.m. Eastern Time
How: Via telephone: Domestic: 888-230-6285
International: 913-312-1279
Via Internet: www.senorx.com
About SenoRx
SenoRx (Nasdaq:SENO), which completed its initial public offering of common stock in March 2007, develops, manufactures and sells minimally invasive medical devices used by breast care specialists for the diagnosis of breast cancer. SenoRx's field sales organization serves over 1,000 breast diagnostic and treatment centers in the United States and Canada. With 18 products that have already received FDA 510(k) clearance across the continuum of breast care, SenoRx is developing additional minimally invasive products for diagnosis and treatment of breast cancer. For more information, visit the company's website at www.senorx.com.
The SenoRx, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3605